Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 1840  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded59    
    Comments [Add]    

Recommend this journal


Year : 2020  |  Volume : 68  |  Issue : 4  |  Page : 769--773

ISNO Position Statement on Treatment Guidance in Neuro-oncology During Pandemics

1 Department of Radiation Oncology, Indian Society of Neuro-Oncology (ISNO), Tata Memorial Centre, Mumbai, Maharashtra, India
2 Institute of Neurosciences, Medanta - The Medicity, Delhi, India
3 Neuro-Surgery, Yashoda Hospitals, Hyderabad, Telangana, India
4 Department of Medical Oncology, Cytecare Hospital, Bengaluru, Karnataka, India
5 Division of Pediatric Hematology Oncology/BMT, SRCC Children's Hospital, Mumbai, Maharashtra, India
6 Super Speciality Cancer Institute and Hospital, Lucknow, Uttar Pradesh, India
7 Apollo Proton Cancer Centre, Chennai, Tamil Nadu, India

Correspondence Address:
Dr. Tejpal Gupta
Department of Radiation Oncology, Indian Society of Neuro-Oncology (ISNO), ACTREC, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Kharghar, Navi Mumbai, Maharashtra - 400 012
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0028-3886.293460

Rights and Permissions

The entire world including India is currently fighting the coronavirus disease 19 (COVID-19) pandemic that threatens to disrupt healthcare systems globally in terms of capacity and resources. This outbreak necessitates an urgent review of existing management guidelines for commonly encountered tumors of the brain and central nervous system (CNS). Such a review should include a reassessment of benefit-risk ratio to align with local, national, and international priorities without compromising on delivery of care in terms of safety, compassion, efficiency, and effectiveness. Towards this end, the Indian Society of Neuro-Oncology (ISNO) constituted an online expert panel with adequate representation from all major treatment modalities (neuro-surgery, radiation oncology, and pediatric/medical oncology) to formulate a “COVID-19 context” position statement to guide the care of neuro-oncology patients during the ongoing crisis. The ISNO position statement suggests graded prioritization (based on clinical presentation, type of tumor, expected prognosis, and relevance of immediate therapy) for efficient utilization of resources and provides a framework through a set of general considerations, treatment modality-based considerations, and disease-specific considerations for the guidance of healthcare professionals involved in the delivery of care and services to patients with CNS tumors. The views expressed herein represent the current consensus of key opinion leaders from within the Indian neuro-oncology community and should not be in any case considered binding medically or legally to individual physicians and/or hospitals who may formulate their guidelines based on local setup and health-environment and update them periodically based on emerging evidence through the COVID-19 pandemic.


Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow